Extracellular Matrix: Matrix Proteoglycans

Encyclopedia of Respiratory Medicine, Four-Volume Set

Volumn , Issue , 2006, Pages 184-188

  Frevert, C W ^a   Wight, T N ^b  

^a VA Puget Sound Medical Center   (United States)

^b HOPE HEART INSTITUTE   (United States)

Author keywords

Chondroitin sulfate; Extracellular matrix; Glycosaminoglycans; Heparan sulfate; Hyaluronan; Perlecan; Proteoglycans; Versican

Indexed keywords

EID: 77953164815     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-12-370879-6/00150-2     Document Type: Chapter

References (15)

1. Allen B.L., Filla M.S., Rapraeger A.C. Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. Journal of Cell Biology 2001, 155(5):845-858.
2. Bensadoun E.S., Burke A.K., Hogg J.C., Roberts C.R. Proteoglycan deposition in pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 1996, 154(6 Pt 1):1819-1828.
3. Cavalcante F.S., Ito S., Brewer K., et al. Mechanical interactions between collagen and proteoglycans. implications for the stability of lung tissue. Journal of Applied Physiology 2005, 98(2):672-679.
4. Frevert C.W., Kinsella M.G., Vathanaprida C., et al. Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. American Journal Respiratory Cell and Molecular Biology 2003, 28(4):464-472.
5. Fust A., LeBellego F., Iozzo R.V., Roughley P.J., Ludwig M.S. Alterations in lung mechanics in decorin-deficient mice. American Journal of Physiology: Lung Cellular and Molecular Physiology 2005, 288(1):L159-L166.
6. Giri S.N., Hyde D.M., Braun R.K., et al. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochemical Pharmacology 1997, 54(11):1205-1216.
7. Halfter W., Dong S., Schurer B., Cole G.J. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. Journal of Biological Chemistry 1998, 273(39):25404-25412.
8. Karlinsky J.B., Bucay P.J., Ciccolella D.E., Crowley M.P. Effects of intratracheal endotoxin administration on hamster lung glycosaminoglycans. American Journal of Physiology 1991, 261(2 Pt 1):L148-L155.
9. Noonan D.M., Fulle A., Valente P., et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. Journal of Biological Chemistry 1991, 266(34):22939-22947.
10. Sannes P.L., Khosla J., Li C.M., Pagan I. Sulfation of extracellar matrices modifies growth factor effects on type II cells on laminin substrata. American Journal of Physiology 1998, 275(4Pt 1):L701-L708.
11. Sasaki T., Fukai N., Mann K., et al. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO Journal 1998, 17(15):4249-4256.
12. Smits N.C., Robbesom A.A., Versteeg E.M., et al. Heterogeneity of heparan sulfates in human lung. American Journal of respiratory Cell and Molecular Biology 2004, 30(2):166-173.
13. Spillmann D., Witt D., Lindahl U. Defining the interleukin-8-binding domain of heparan sulfate. Journal of Biological Chemistry 1998, 273(25):15487-15493.
14. Tapanadechopone P., Hassell J.R., Rigatti B., Couchman J.R. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan. Biochemical and Biophysical Research Communications 1999, 265(3):680-690.
15. Westergren-Thorsson G., Chakir J., Lafreniere-Allard M.J., Boulet L.P., Tremblay G.M. Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. International Journal of Biochemistry and Cell Biology 2002, 34(10):1256-1267.